149 related articles for article (PubMed ID: 7731943)
1. Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature.
Esteban JM; Somlo G
Mod Pathol; 1995 Jan; 8(1):59-64. PubMed ID: 7731943
[TBL] [Abstract][Full Text] [Related]
2. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
3. T-lymphocyte subsets in the lesional skin of allogeneic and autologous bone marrow transplant patients.
Paller AS; Nelson A; Steffen L; Gottschalk L; Kaizer H
Arch Dermatol; 1988 Dec; 124(12):1795-801. PubMed ID: 3056281
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
Gruhn B; Häfer R; Kosmehl H; Fuchs D; Zintl F
Bone Marrow Transplant; 1998 May; 21(9):901-7. PubMed ID: 9613782
[TBL] [Abstract][Full Text] [Related]
5. LN-3: a diagnostic adjunct in cutaneous graft-versus-host disease.
Synovec MS; Braddock SW; Jones J; Linder J
Mod Pathol; 1990 Nov; 3(6):643-7. PubMed ID: 1702211
[TBL] [Abstract][Full Text] [Related]
6. Expression of MHC class I and II antigens by keratinocytes and enterocytes in acute graft-versus-host disease. Newcastle Bone Marrow Transplant Group.
Sviland L; Pearson AD; Green MA; Eastham EJ; Malcolm AJ; Proctor SJ; Hamilton PJ
Bone Marrow Transplant; 1989 May; 4(3):233-8. PubMed ID: 2659108
[TBL] [Abstract][Full Text] [Related]
7. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
9. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte apoptosis following bone marrow transplantation: evidence for CTL-dependent and -independent pathways.
Jerome KR; Conyers SJ; Hansen DA; Zebala JA
Bone Marrow Transplant; 1998 Aug; 22(4):359-66. PubMed ID: 9722071
[TBL] [Abstract][Full Text] [Related]
11. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
[TBL] [Abstract][Full Text] [Related]
12. Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow.
Heldal D; Brinch L; Evensen SA; Tjønnfjord GE; Aamodt G; Elgjo K; Sviland L
Bone Marrow Transplant; 2004 Aug; 34(4):345-50. PubMed ID: 15170163
[TBL] [Abstract][Full Text] [Related]
13. The skin biopsy in the diagnosis of acute graft-versus-host disease in man.
Sale GE; Lerner KG; Barker EA; Shulman HM; Thomas ED
Am J Pathol; 1977 Dec; 89(3):621-36. PubMed ID: 23008
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
[TBL] [Abstract][Full Text] [Related]
15. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.
Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS
Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738
[TBL] [Abstract][Full Text] [Related]
16. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group.
Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Kelly PJ; Malcolm AJ; Proctor SJ
Bone Marrow Transplant; 1995 Dec; 16(6):777-82. PubMed ID: 8750269
[TBL] [Abstract][Full Text] [Related]
17. A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease.
Massi D; Franchi A; Pimpinelli N; Laszlo D; Bosi A; Santucci M
Am J Clin Pathol; 1999 Dec; 112(6):791-800. PubMed ID: 10587702
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of the CD45RO(+) and CD20(+) lymphoid marrow population following allogeneic bone marrow transplantation for Ph(+) CML.
Thiele J; Kvasnicka HM; Beelen DW; Welter A; Schneider S; Leder LD; Schaefer UW
Bone Marrow Transplant; 2001 Feb; 27(4):425-31. PubMed ID: 11313672
[TBL] [Abstract][Full Text] [Related]
20. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease.
Marra DE; McKee PH; Nghiem P
J Am Acad Dermatol; 2004 Oct; 51(4):543-6. PubMed ID: 15389188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
